200 related articles for article (PubMed ID: 31441200)
1. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.
Kappel S; Stokłosa P; Hauert B; Ross-Kaschitza D; Borgström A; Baur R; Galván JA; Zlobec I; Peinelt C
Mol Oncol; 2019 Nov; 13(11):2393-2405. PubMed ID: 31441200
[TBL] [Abstract][Full Text] [Related]
2. Small Molecular Inhibitors Block TRPM4 Currents in Prostate Cancer Cells, with Limited Impact on Cancer Hallmark Functions.
Borgström A; Hauert B; Kappel S; Zoni E; Kiener M; Stokłosa P; Baur R; Spahn M; Kruithof-de Julio M; Peinelt C
J Mol Biol; 2021 Aug; 433(17):166665. PubMed ID: 33058873
[TBL] [Abstract][Full Text] [Related]
3. p53 alters intracellular Ca
Kappel S; Ross-Kaschitza D; Hauert B; Rother K; Peinelt C
Cell Calcium; 2022 Jun; 104():102591. PubMed ID: 35500522
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.
Holzmann C; Kappel S; Kilch T; Jochum MM; Urban SK; Jung V; Stöckle M; Rother K; Greiner M; Peinelt C
Oncotarget; 2015 Dec; 6(39):41783-93. PubMed ID: 26496025
[TBL] [Abstract][Full Text] [Related]
5. TRPM4 in Cancer-A New Potential Drug Target.
Borgström A; Peinelt C; Stokłosa P
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562811
[TBL] [Abstract][Full Text] [Related]
6. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
[TBL] [Abstract][Full Text] [Related]
7. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
Su F; Wang BF; Zhang T; Hou XM; Feng MH
Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
9. A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca
Wang C; Chen J; Kuang Y; Cheng X; Deng M; Jiang Z; Hu X
Int J Biol Sci; 2022; 18(14):5575-5590. PubMed ID: 36147460
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
Hong X; Yu JJ
Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells.
Stokłosa P; Borgström A; Hauert B; Baur R; Peinelt C
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771564
[TBL] [Abstract][Full Text] [Related]
12. A Novel Role of the TRPM4 Ion Channel in Exocytosis.
Stokłosa P; Kappel S; Peinelt C
Cells; 2022 May; 11(11):. PubMed ID: 35681487
[TBL] [Abstract][Full Text] [Related]
13. TRPM4 channel and cancer.
Gao Y; Liao P
Cancer Lett; 2019 Jul; 454():66-69. PubMed ID: 30980865
[TBL] [Abstract][Full Text] [Related]
14. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
[TBL] [Abstract][Full Text] [Related]
15. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells.
Sagredo AI; Sagredo EA; Cappelli C; Báez P; Andaur RE; Blanco C; Tapia JC; Echeverría C; Cerda O; Stutzin A; Simon F; Marcelain K; Armisén R
Mol Oncol; 2018 Feb; 12(2):151-165. PubMed ID: 28614631
[TBL] [Abstract][Full Text] [Related]
16. Aberrant TRPM4 expression in MLL-rearranged acute myeloid leukemia and its blockade induces cell cycle arrest via AKT/GLI1/Cyclin D1 pathway.
Wang F; Wu P; Gong S; Chen Y; Gao J; Wang S; Shen Q; Tao H; Hua F; Zhou Z; Zou Z; Ma T; Jia Y
Cell Signal; 2020 Aug; 72():109643. PubMed ID: 32320859
[TBL] [Abstract][Full Text] [Related]
17. Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis.
Ghosh S; Yang R; Duraki D; Zhu J; Kim JE; Jabeen M; Mao C; Dai X; Livezey MR; Boudreau MW; Park BH; Nelson ER; Hergenrother PJ; Shapiro DJ
Cancer Res; 2023 Sep; 83(18):3115-3130. PubMed ID: 37522838
[TBL] [Abstract][Full Text] [Related]
18. KCTD5, a novel TRPM4-regulatory protein required for cell migration as a new predictor for breast cancer prognosis.
Rivas J; Díaz N; Silva I; Morales D; Lavanderos B; Álvarez A; Saldías MP; Pulgar E; Cruz P; Maureira D; Flores G; Colombo A; Blanco C; Contreras HR; Jaña F; Gallegos I; Concha ML; Vergara-Jaque A; Poblete H; González W; Varela D; Trimmer JS; Cáceres M; Cerda O
FASEB J; 2020 Jun; 34(6):7847-7865. PubMed ID: 32301552
[TBL] [Abstract][Full Text] [Related]
19. Suppression of CLC-3 reduces the proliferation, invasion and migration of colorectal cancer through Wnt/β-catenin signaling pathway.
Mu H; Mu L; Gao J
Biochem Biophys Res Commun; 2020 Dec; 533(4):1240-1246. PubMed ID: 33069359
[TBL] [Abstract][Full Text] [Related]
20. TRPM4 enhances cell proliferation through up-regulation of the β-catenin signaling pathway.
Armisén R; Marcelain K; Simon F; Tapia JC; Toro J; Quest AF; Stutzin A
J Cell Physiol; 2011 Jan; 226(1):103-9. PubMed ID: 20625999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
